Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster study of combined DTPa/Hib versus separate DTPa and Hib vaccines in previously primed Chinese toddlers
2015-001507-31Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + haemophilus influenzae type b conjugate vaccine, diphtheria toxoid + tetanus toxoid + acellular pertussis and haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis and 1 more (2 arms), sponsored by GSK. Primary endpoint: Immune response one month after booster vaccination.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + haemophilus influenzae type b conjugate vaccinediphtheria toxoid + tetanus toxoid + acellular pertussishaemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussisHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2015-001507-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001507-31.